- Home
- TARA vs LAZR Comparison
TARA vs LAZR Comparison
Compare TARA & LAZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- LAZR
- Stock Information
- Founded
- TARA N/A
- LAZR 2012
- Country
- TARA United States
- LAZR United States
- Employees
- TARA N/A
- LAZR N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- LAZR Auto Parts:O.E.M.
- Sector
- TARA Health Care
- LAZR Consumer Discretionary
- Exchange
- TARA Nasdaq
- LAZR Nasdaq
- Market Cap
- TARA 126.5M
- LAZR 140.7M
- IPO Year
- TARA N/A
- LAZR N/A
- Fundamental
- Price
- TARA $3.33
- LAZR $3.20
- Analyst Decision
- TARA Strong Buy
- LAZR Hold
- Analyst Count
- TARA 7
- LAZR 7
- Target Price
- TARA $20.67
- LAZR $37.83
- AVG Volume (30 Days)
- TARA 452.5K
- LAZR 4.0M
- Earning Date
- TARA 08-05-2025
- LAZR 08-12-2025
- Dividend Yield
- TARA N/A
- LAZR N/A
- EPS Growth
- TARA N/A
- LAZR N/A
- EPS
- TARA N/A
- LAZR N/A
- Revenue
- TARA N/A
- LAZR $73,313,000.00
- Revenue This Year
- TARA N/A
- LAZR $16.78
- Revenue Next Year
- TARA N/A
- LAZR $29.92
- P/E Ratio
- TARA N/A
- LAZR N/A
- Revenue Growth
- TARA N/A
- LAZR N/A
- 52 Week Low
- TARA $1.60
- LAZR $2.52
- 52 Week High
- TARA $10.48
- LAZR $26.70
- Technical
- Relative Strength Index (RSI)
- TARA 55.94
- LAZR 51.06
- Support Level
- TARA $3.25
- LAZR $2.98
- Resistance Level
- TARA $3.23
- LAZR $3.86
- Average True Range (ATR)
- TARA 0.17
- LAZR 0.29
- MACD
- TARA 0.04
- LAZR 0.08
- Stochastic Oscillator
- TARA 81.25
- LAZR 43.59
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About LAZR Luminar Technologies Inc.
Luminar Technologies Inc is an automotive technology company ushering in a new era of vehicle safety and autonomy. It operates its business through the following segments: Autonomy Solutions and Advanced Technologies and Services. The majority of its revenue is generated from the Autonomy Solutions segment, which engages in the design, manufacturing, and sale of LiDAR sensors, catering mainly to the OEMs in the automobile, commercial vehicle, robo-taxi, and adjacent industries. The Advanced Technologies and Services segment provides semiconductors and related components, as well as design, test, and consulting services to the Autonomy Solutions segment and various third-party customers. Geographically, the company derives its key revenue from North America.